News & Events
Stay up to date with the latest news, learning rounds, and research from CanRIO and our members.
New Article Alert! Acrocyanosis after Immunotherapy: A CanRIO Case Series
A new article published by CanRIO members in the Journal of Rheumatology (April 2025) describes 8 new cases of acral digital ischemia associated with ICI. See link for details: https://www.jrheum.org/
Upcoming Learning Rounds: Dr. Shahin Jamal
Join Dr. Shahin Jamal as she presents on rheumatic irAEs asssociated with cancer immunotherapy! Hosted by the University of Saskatchewan on Tuesday, March 25, 2025 at 8:30am CST (9:30am EST/7:30am PST
Learning Rounds
Virtual Learning Rounds (for clinicians, researchers, and medical trainees) occur approximately quarterly and are advertised via our mailing list. To sign up for our mailing list (as well as access re
New Article Alert! Chronicity of ICI-related Inflammatory Arthritis
A new article published by CanRIO members in ACR Open Rheumatology (February 18, 2025) suggests that ICI related inflammatory arthritis (IA) frequently persists after ICI discontinuation. Chronic ICI-
CanRIO Researcher Awarded an Arthritis Society of Canada Grant!
Congratulations to Dr. Marie Hudson who has been awarded a Arthritis Society of Canada grant to study the mechanisms underlying rheumatic immune related adverse events! Using a large bank of tissue sa
Early Adalimumab Induction for Treatment of Steroid-Dependent Checkpoint Inhibitor Associated Inflammatory Arthritis: A Pragmatic Randomized Clinical Trial
Work in progress! Dr. Shahin Jamal and Dr. Tom Appleton are leading a study on Early Adalimumab Induction for Treatment of Steroid-Dependent Checkpoint Inhibitor Associated Inflammatory Arthritis: A P
CanRIO Researchers Awarded a 2023 CIORA Grant!
Congratulations to Dr. Shahin Jamal and Dr. Tom Appleton on receiving a Canadian Initiative for Outcomes in Rheumatology cAre (CIORA) grant from the Canadian Rheumatology Association Foundation (CRAF)
Introducing our CanRIO Twitter account!
We are pleased to share our new Twitter account! @CanRIO_Tweets Keep connected and updated with news, research, initiatives, and collaborations! Check out the link below. https://twitter.com/CanRIO_Tw
CanRIO Recommendations for the Assessment and Management of Rheumatic Immune Related Adverse Events from Cancer Immunotherapy
Coming 2024/2025! With support from the Canadian Rheumatology Association (CRA) Guidelines Committee, CanRIO has assembled a working group of rheumatologists, oncologist and patient representative to
A Prospective Cohort Study of Adults with Rheumatic Immune Related Adverse Events associated with Cancer Immunotherapies (CanRIO)
Currently recruiting! This is an ongoing prospective, multi-centre, Canadian study looking at clinical phenotypes, outcomes and biomarker profiles of adults with rheumatic immune related adverse event
Welcome to CanRIO.ca
CanRIO is thrilled to launch the first educational website dedicated to the rheumatic complications of immunotherapy. We hope that this website will serve as an educational resource to rheumatologists
Hot off the Press!
CanRIO has just published its second national case series. This retrospective cohort study included 27 patients with pre-existing autoimmune disease (PAD) treated with immunotherapy. Consistent with p
No items in this category.
Stay Updated
Newsletter sign-up coming soon. Check back here for the latest news, publication announcements, and information about upcoming learning rounds.